Clinical Trials Sought to Test GLP1-RA, Which May Promote Weight Loss

Clinical Trials Sought to Test GLP1-RA, Which May Promote Weight Loss

314181

Clinical Trials Sought to Test GLP1-RA, Which May Promote Weight Loss

A class of medications called GLP-1 receptor agonists (GLP1-RA) may help reduce appetite and promote weight loss for people with Prader-Willi syndrome (PWS), according to a review paper. The paper’s authors called for clinical trials to test these medicines in people with PWS. Their paper, “The effects of glucagon-like peptide (GLP)-1 receptor agonists on weight and glycaemic control in Prader-Willi syndrome: A systematic review,” was published in the journal Clinical Endocrinology. Recommended Reading June 2,…

You must be logged in to read/download the full post.